In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients

Allergol Immunopathol (Madr). 1993 Jul-Aug;21(4):136-40.

Abstract

In order to assess the immune mechanisms triggered by an immunosuppressive regimen consisting of prophylactic antilymphocyte globulin plus low-dose cyclosporine A and steroids, we studied the short-term evolution of both, anti donor in vitro alloresponse and peripheral blood T cell subsets in 21 recipients of a cadaveric kidney allograft. Spleen cells from cadaveric donors and peripheral blood lymphocytes from the respective recipients pretransplant (pre-Tx), at three and six months posttransplant (post-Tx) were obtained to perform one-way mixed lymphocyte cultures and flow cytometry analysis of lymphocyte subsets. The results indicated the development of donor-specific mixed lymphocyte culture (MLC) hyporesponsiveness as early as three months post-Tx, paralleled by a decrease in CD4+CD29+ helper-inducer cells and by an increase in CD8+CD45RA+ suppressor lymphocytes in peripheral blood. These changes were reflected in a very good clinical outcome of the patients. The present results further suggest that suppression of the immune system just before transplantation is a suitable method to induce early specific hyporesponsiveness to the allograft.

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use*
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / prevention & control
  • Histocompatibility
  • Humans
  • Immune Tolerance*
  • Kidney Transplantation / immunology*
  • Lymphocyte Culture Test, Mixed
  • Male
  • Middle Aged
  • Prednisone / therapeutic use*
  • Premedication
  • T-Lymphocyte Subsets*
  • Tissue Donors
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • Cyclosporine
  • Prednisone